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Introduction
Diabetes is a chronic disease, which deteriorates the
quality of life of patients and reduces the life span. In
the treatment of diabetes, first behavioral methods are
used, then oral anti-diabetic drugs, then, in the course
of the disease progress, a combined therapy (non-insulin
plus insulin) and finally, solely insulin therapy. Unfortu-
nately, many patients are afraid of including insulin for
the treatment. By delaying the proper therapy, patients
expose themselves to the increased risk of complications
due to the macro- and microvascular pathologies. The
prevention, prediction and minimalizing of the short-
and long-term complications is a main focus of health
care and it is at the front of the activities of many local
and global organizations (see e.g. [1,2]).
Scientific background
Our two years long study (2011-2012) on the quality of
life of the out clinic patients in Wroclaw suffered from
the diabetes type 2, revealed the following: 1 quality of
life was highest in patients treated with oral anti-diabetic
drugs and the lowest in patients treated with insulin,
only, and 2. general physical health of patients was worse
than the general mental health. Moreover, we stated that
the patients are more prone to develop depression than
the general population. Besides of treatment method,
within the factors that influence the quality of life, we
found: age, disease duration, gender, obesity and presence
of other diseases, including diabetes complications.
One of the frustrating for patient complication, proble-
matic in the treatment, is development of the diabetes
foot, which is very often leading to the amputation,
which in turn, shorten the patients’ life. Therefore,
remote monitoring of the feet condition may allow for
due to time medical intervention.
Outlook and expert recommendations
Prevention of the complication as diabetic food may be
possible by assessing the conditions for the pathology
development. We expect that the local temperature dis-
tribution, as well as podobarographic data differ in
healthy population and diabetes patients. Multi-institu-
tional clinical study will help to gather enough data
which may be exploited for finding the predictive factors
of diabetic foot development. In patients already suffer-
ing from this complication, it could be possible to react
promptly in order to prevent amputation. Such an
approach will allow treating patients individually, simul-
taneously in the most economic way.
Authors’ details
1Institute of Biomedical Engineering and Instrumentation, Wroclaw University
of Technology, 50-370 Wroclaw, Wybrzeze Wyspianskiego 27, Poland.
2“Dobrzynska” Medical Center, Department of Diabetology, 50-403 Wroclaw,
ul. Dobrzynska 21/23, Poland. 3Faculty of Physiotherapy, University School of
Physical Education, 51-612 Wrocław, ul. Paderewskiego 35, Poland.





Cite this article as: Podbielska et al.: Quality of life of people suffering
from the diabetes type 2 – examination of the influence of various
factors to prevent complications. EPMA Journal 2014 5(Suppl 1):A72.
* Correspondence: halina.podbielska@pwr.wroc.pl
1Institute of Biomedical Engineering and Instrumentation, Wroclaw University
of Technology, 50-370 Wroclaw, Wybrzeze Wyspianskiego 27, Poland
Full list of author information is available at the end of the article
Podbielska et al. EPMA Journal 2014, 5(Suppl 1):A72
http://www.epmajournal.com/content/5/S1/A72
© 2014 Podbielska et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
